Market closed
Elevance Health/$ELV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Elevance Health
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Ticker
$ELV
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
104,200
Website
Elevance Health Metrics
BasicAdvanced
$91B
15.65
$25.68
0.84
$6.52
1.70%
Price and volume
Market cap
$91B
Beta
0.84
52-week high
$556.17
52-week low
$362.21
Average daily volume
1.7M
Dividend rate
$6.52
Financial strength
Current ratio
1.452
Quick ratio
1.323
Long term debt to equity
70.531
Total debt to equity
75.392
Dividend payout ratio (TTM)
25.22%
Interest coverage (TTM)
7.76%
Management effectiveness
Return on assets (TTM)
5.58%
Return on equity (TTM)
14.77%
Valuation
Price to earnings (TTM)
15.651
Price to revenue (TTM)
0.527
Price to book
2.21
Price to tangible book (TTM)
96.85
Price to free cash flow (TTM)
20.459
Dividend yield (TTM)
1.62%
Forward dividend yield
1.70%
Growth
Revenue change (TTM)
3.19%
Earnings per share change (TTM)
1.81%
3-year revenue growth (CAGR)
8.44%
3-year earnings per share growth (CAGR)
0.96%
3-year dividend per share growth (CAGR)
12.99%
What the Analysts think about Elevance Health
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Elevance Health Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Elevance Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Elevance Health News
AllArticlesVideos
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
Seeking Alpha·23 hours ago
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Seeking Alpha·3 days ago
Alphabet's Verily to sell Granular insurance business to Elevance Health
CNBC·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Mar10
Elevance Health
Dividend·Ex-dividend
Mar25
Elevance Health
Dividend·Payment
$1.71
Per share
FAQs
What’s the current market cap for Elevance Health stock?
Elevance Health (ELV) has a market cap of $91B as of February 27, 2025.
What is the P/E ratio for Elevance Health stock?
The price to earnings (P/E) ratio for Elevance Health (ELV) stock is 15.65 as of February 27, 2025.
Does Elevance Health stock pay dividends?
Yes, the Elevance Health (ELV) stock pays dividends to shareholders. As of February 27, 2025, the dividend rate is $6.52 and the yield is 1.7%. Elevance Health has a payout ratio of 25.22% on a trailing twelve-month basis.
When is the next Elevance Health dividend payment date?
The next Elevance Health (ELV) dividend payment is scheduled for March 25, 2025.
What is the beta indicator for Elevance Health?
Elevance Health (ELV) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.